← Open Payments lookup

MARK LEJSEK: Open Payments

NPI 1891016010 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,240 in 134 payments from 17 companies in 2025. Trend: 2023 $2,853 · 2024 $2,589 · 2025 $2,240

Food & beverage: $2,240
CompanyPaymentsAmount
Alkermes, Inc.23$421
ABBVIE INC.28$385
Tris Pharma Inc16$282
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$266
Corium, LLC10$228
Neos Therapeutics, LP20$187
Bausch Health US, LLC4$83
E.R. Squibb & Sons, L.L.C.4$76
Otsuka America Pharmaceutical, Inc.4$63
Axsome Therapeutics, Inc.3$55

Products named: LYBALVI, VRAYLAR, CAPLYTA, Azstarys, Onyda XR, Adzenys XR-ODT, Dyanavel XR, APLENZIN.

Industry payments across TX — which companies pay providers there.